Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Piafsky, KM, AU - Ogilvie, RI: TI - Dosage of theophylline in bronchial asthma. JA - N Engl J Med PY - 1975/// VL - 292 SP - 1218 EP - 1222 ER - TY - JOUR AU - Mahler, DA, AU - Matthay, RA, AU - Snyder, PE, AU - Wells, CK, AU - Loke, J: TI - Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease. JA - Am Rev Respir Dis PY - 1985/// VL - 131 SP - 22 EP - 25 ER - TY - JOUR AU - Barr, PA: TI - Weaning very low birth weight infants from mechanical ventilation using intermittent mandatory ventilation and theophylline. JA - Arch Dis Child PY - 1976/// VL - 53 SP - 598 EP - 600 ER - TY - JOUR AU - Davi, MJ, AU - Sankanan, K, AU - Simons, KJ: TI - Physiologic changes induced by theophylline in the treatment of apnea in preterm infants. JA - J Pediatr PY - 1978/// VL - 92 SP - 91 EP - 95 ER - TY - JOUR AU - Lakshminarayan, S, AU - Sahn, SA, AU - Weil, JV: TI - Effects of aminophylline on ventilatory respiratory responses in normal men. JA - Am Rev Respir Dis PY - 1978/// VL - 117 SP - 33 EP - 38 ER - TY - JOUR AU - Aubier, M, AU - Roussos, C: TI - Effects of theophylline on respiratory muscle function. JA - Chest PY - 1985/// VL - 88 SP - 915 EP - 975 ER - TY - JOUR AU - Bukowskyi, M: TI - Theophylline: an overview. JA - Rational drug therapy PY - 1985/// VL - 22 SP - 1 EP - 5 ER - TY - JOUR AU - Matthay, RA: TI - Favourable cardiovascular effects of theophylline in Chronic obstructive pulmonary disease. JA - Chest PY - 1987/// VL - 92 SP - 22 EP - 26 ER - TY - JOUR AU - Hasegawa, T, AU - Takagi, K, AU - Ogura, Y: TI - Studies on the temporal variations in the pharmacokinetics and metabolism of theophylline. JA - Chem Pharm Bull PY - 1987/// VL - 35 SP - 2079 EP - 2084 ER - TY - JOUR AU - Vree, TB, AU - Martea, M, AU - Tiggeler, RGL, AU - Hekster, YA, AU - Hafkenscheid, JCM: TI - Pharmakokinetics of theophyiline and its metabolites in a patient undergoing continuous ambulatory peritoneal dialysis. JA - Clin Pharmacokinet PY - 1988/// VL - 15 SP - 390 EP - 393 ER - TY - JOUR AU - Cornish, LH, AU - Christman, A: TI - A study of the metabolism of theobromine, theophylline and caffeine in man. JA - J Biol Chem PY - 1957/// VL - 228 SP - 315 EP - 323 ER - TY - JOUR AU - Birkette, DJ, AU - Miners, JO: TI - Atwood: Secondary metabolism of theophylline biotransformation products in man: rate of formation of 1-methyl uric acid. JA - Br J Clin Pharmacol PY - 1983/// VL - 15 SP - 117 EP - 119 ER - TY - JOUR AU - Jenne, JW, AU - Wyze, E, AU - Rood, FS, AU - Macdonald, FM: TI - Pharmcokinetics of theophylline. JA - Clin Pharm Ther PY - 1972/// VL - 13 SP - 349 EP - 360 ER - TY - JOUR AU - Goerz, G: TI - Animal models for cutaneous drug metabolizing enzymes. JA - Models in Dermatology PY - 1987/// VL - III SP - 93 EP - 105 ER - TY - JOUR AU - Bronaugh, RL: TI - Determination of percutaneous absorption by in vitro techniques. JA - Percutaneous Absorption in Dermatology PY - 1985/// VL - 6 SP - 267 EP - 279 ER - TY - JOUR AU - Pham, M, AU - Magdalou, J, AU - Totis, M, AU - Fournel-Gigleux, S, AU - Siest, G, AU - Hammock, BD: TI - Characterisation of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin. JA - Biochem Pharmacol PY - 1989/// VL - 38 SP - 2187 EP - 2194 M3 - 10.1016/0006-2952(89)90075-0 N1 - 10.1016/0006-2952(89)90075-0 UR - http://dx.doi.org/10.1016/0006-2952(89)90075-0 ER - TY - JOUR AU - Bronaugh, RL, AU - Stewart, RF, AU - Storm, JE: TI - Extent of cutaneous metabolism during percutaneous absorption of xenobiotics. JA - Toxicol Appl Pharmacol PY - 1989/// VL - 99 SP - 534 EP - 543 M3 - 10.1016/0041-008X(89)90160-9 N1 - 10.1016/0041-008X(89)90160-9 UR - http://dx.doi.org/10.1016/0041-008X(89)90160-9 ER - TY - JOUR AU - Berthou, F, AU - Ratanasavanh, D, AU - Alix, D, AU - Carlhat, D, AU - Richie, C, AU - Gullouzo, A: TI - Caffeine and theophylline metabolism in newborn and adult human hepatocytes; comparison with adult rat hepatocytes. JA - Biochem Pharmcol PY - 1988/// VL - 37 SP - 3691 EP - 3700 ER - TY - GEN AU - Arnaud, MJ: TI - Products of metabolism of caffeine. JA - Caffeine Perspective from Recent Research PY - 1984/// VL - SP - 3 EP - 38 ER - TY - JOUR AU - Aranda, JV, AU - Louridas, AT, AU - Vitello, BV, AU - Aldridge, PTA, AU - Haber, R: TI - Metabolism of theophylline to caffeine in human fetal liver. JA - Science PY - 1979/// VL - 206 SP - 1319 EP - 1321 ER - TY - JOUR AU - Lohman, SM, AU - Miech, RE: TI - Theophylline metabolism by the rat liver microsomal system. JA - J Clin Pharmacol Exp Ther PY - 1976/// VL - 196 SP - 213 EP - 225 ER - TY - JOUR AU - Robson, RA, AU - Matheus, AP, AU - Miners, JU, AU - McManus, ME, AU - Meyer, UA, AU - Hal, PM, AU - Birkette, DJ: TI - Characterisation of theophylline metabolism in human liver microsomes. JA - Br J Clin Pharmacol PY - 1987/// VL - 24 SP - 293 EP - 300 ER - TY - JOUR AU - Peck, CC, AU - Conner, DP, AU - Brenda, BJ: TI - Outward transdermal migration of theophylline. JA - Pharmacol Skin PY - 1987/// VL - 1 SP - 201 EP - 208 ER - TY - JOUR AU - Buss, D, AU - Leopold, D, AU - Smith, AP, AU - Routeledge, PA: TI - Determination of the plasma protein binding of theophylline in health. JA - Br J Clin Pharmacol PY - 1983/// VL - 15 SP - 399 EP - 405 ER - TY - JOUR AU - Cooper, ER: TI - JA - Solution Behaviour of Surfactants PY - 1982/// VL - 2 SP - 1505 EP - 1516 ER - TY - JOUR AU - Touitou, E, AU - Fabin, B: TI - Altered skin permeation of a highly lipophilic molecule: tetra hydrocannabind. JA - Int J Pharm PY - 1988/// VL - 43 SP - 17 EP - 22 M3 - 10.1016/0378-5173(88)90053-1 N1 - 10.1016/0378-5173(88)90053-1 UR - http://dx.doi.org/10.1016/0378-5173(88)90053-1 ER - TY - JOUR AU - Caldwell, J, AU - Lancaster, R, AU - Monks, TJ, AU - Smith, RL: TI - The influence of dietary methylxanthines on the metabolism and pharmacokinetics of intravenously administered theophylline. JA - Br J Clin Toxicol PY - 1979/// VL - 4 SP - 637 EP - 638 ER - TY - JOUR AU - Persson, CG, AU - Anderson, KE: TI - Respiratory and cardiovascular effects of 3-methylxanthines, a metabolite of theophylline. JA - Acta Pharmacol Toxicol PY - 1977/// VL - 49 SP - 529 EP - 536 ER - TY - JOUR AU - Miller, M, AU - Opheim, KE, AU - Raisys, VA, AU - Motulsky, AG: TI - Theophylline metabolism: variation and genetics. JA - Clin Pharm Ther PY - 1984/// VL - 35 SP - 170 EP - 182 ER - TY - JOUR AU - Bruce, JA, AU - Blake, JA, AU - Rogers, NJ, AU - Hussain, MA: TI - Transdermal oxymorphone formulation development and methods for evaluating flux and lag times for two skin permeation-enhancing vehicles. JA - J Pharm Sciences PY - 1990/// VL - 79 SP - 1072 EP - 1076 ER -